REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regio... (rash and/or joint pain. There have be...)

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

Date:2/4/2008

rash and/or joint pain.

There have been rare cases of serious liver injury in people taking REMICADE, some fatal. Tell your doctor if you have liver problems and contact your doctor immediately if you develop symptoms such as jaundice (yellow skin and eyes), dark brown urine, right-sided abdominal pain, fever or severe fatigue.

Blood disorders have been reported, some fatal. Tell your doctor if you develop possible signs of blood disorders such as persistent fever, bruising, bleeding or paleness while taking REMICADE. Nervous system disorders have also been reported. Tell your doctor if you have or have had a disease that affects the nervous system, or if you experience any numbness, weakness, tingling, visual disturbances or seizures while taking REMICADE.

Allergic reactions, some severe, have been reported during or after infusions with REMICADE. Signs of an allergic reaction include hives, difficulty breathing, chest pain, high or low blood pressure, swelling of face and hands, and fever or chills. Tell your doctor if you have experienced a severe allergic reaction. The most common side effects of REMICADE are: respiratory infections, such as sinus infections and sore throat, headache, rash, coughing and stomach pain.

Please read the Medication Guide for REMICADE and discuss it with your doctor.

About Centocor

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis.

The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders.

(i) Reich K, Menter A, et al. Consistency of Infliximab Response Across

Subg
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
3. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients

Post Your Comments:

(Date:8/18/2008)...O, Aug. 18 /- The next time you consi...ff, it might be worth counting sheep,instead. A se...er in San,Diego, Calif. has found evidence that ta...k of skin cancer., Daniel F. Kripke, M.D.,s artic...eeping pills and cancer, has just been published i...

(Date:8/18/2008)...iates Clinical Trials Phase of Test Development Pr...-FirstCall/ -- Beckman,Coulter, Inc. (NYSE: BEC )...y out its U.S. royalty obligation to Nephromics LL... women,s health. The license is for tests,related ...f preeclampsia, a,leading cause of maternal death....

(Date:8/17/2008)...Australia, Aug. 17 /Xinhua-...ed that the first pivotal Phase 3,clinical trial o...has,completed enrolment., The first efficacy data... the first half of 2009. The trial commenced its d...ruitment target of 250 subjects in June,2008 and c...

(Date:8/14/2008)...N, N.J., Aug. 14 /- Pharmas...aceutical company committed to,discovering, develo...l,infections, reported unaudited financial results... Pharmasset reported a net loss attributable to,co...share of $0.69 for the,quarter ended June 30, 2008...

[1] Prescription Sleeping Pill Use Tied to Cancer [0] Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers [1] Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment [0] Pharmasset Reports Financial Results for Quarter Ended June 30, 2008

...NCISCO--(BUSINESS WIRE)--May 21, 2007 - Gilead Sci...of two long-term studies,evaluating ambrisentan, a...ERA) for the treatment of patients with pulmonary,...are from patients,who originally participated in t..., a Phase II study of patients who had,previously ...

... product recently approved by FDA for long-term,ma...ata demonstrate,first nebulized formoterol fumarat...y powder formoterol, enhanced patient quality of,l...y 20, 2007) – Data presented at the,Internat...(ATS),demonstrate that Perforomist™ (formote...

Other Medicine Technology:Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5 Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6 Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7

Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...shed yesterday looks into support props for care g... elucidates the plight of most relatives // and ca...ften the rehabilitation and restoration of confide... realms of hospital in –patient care. It is the v...

...sions for breast cancer fell by a third between 19...ncy for Healthcare Research and Quality. The decli...cilities for breast cancer surgeries, plus the gro...ns such as lumpectomies, which are typically perfo...

...survivors will be able to do away with invasive br...ch involving stem cells //extracted from their own... who are investigating the potential these cells m.... In animal models, the researchers hope to prove...

...hyam Sarda, a prime accused in the expired blood t...nior police official.// "We have arrested Ghanshy...uced in court," said Gyanwant Singh, deputy commis... department). Ghanshyam's brother, Govind Sarda,...

Other Medicine News:Health News:Breast reconstruction may be possible with fat stem cells 2

Support to care takers of psychiatric patients in pieces?Fewer Women Having Inpatient Breast Cancer Surgery Breast reconstruction may be possible with fat stem cells Accused Arrested in Blood Test Kit Scam

.../Cuff combines the therapeutic benefits of control...ing, and cold to minimize pain. The cuff is anatom...ing maximum cryotherapy. The Elbow Cryo/Cuff is av...c size.,All Cryo/Cuffs can be ordered as a single ...

...; ROM Elbow Orthosis features aluminum cuffs that ...r joint alignment, unique slot/screw adjustment me...l adjustments to cuff position. Cuffs are configur...with contractures.,The hinge can be locked in any...

...CTION Elbow Wrap replaces messy taping and bulky e...s experiencing epicondylitis. Preferred by doctors...y fit. Two overlay straps allow you to apply force...lds the Elbow Wrap comfortably in place. Available...

The Bledsoe Original Arm Brace is designed to handle post-op elbow arthroscopy, severe elbow strains and ligament trauma. The Bledsoe Extender Arm Brace should be used when limited R.O.M. or locked c

Medicine Products:

Elbow Cryo/Cuff™QualCare™ ROM Elbow Orthosis ACTION™ Elbow Wrap Bledsoe Original Arm Brace

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regio...(rash and/or joint pain. There have be...),Health